EBS (EBS) Stock Price & Analysis
EBS (EBS) fell 5.33% to USD 5.68 as of September 10, 2026 at 00:55 UTC, according to Nexqual real-time market data.
EBS last closed at USD 5.68; the session ranged USD 5.61–6.04 on volume of 1,173,941 shares. Market capitalization is —, with a 52-week range of USD 4.36–14.06 (NYQ). Source: Nexqual, September 10, 2026 at 00:55 UTC.
Key Statistics (as of September 10, 2026 at 00:55 UTC)
| Price | USD 5.68 |
|---|---|
| Change | ▼ 5.33% (down) |
| Previous Close | USD 5.68 |
| Open | USD 5.68 |
| Day Range | USD 5.61 – 6.04 |
| 52-Week Range | USD 4.36 – 14.06 |
| Volume | 1,173,941 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (EBS)
Nexqual's technical model rates EBS "NEUTRAL" based on 2 bullish and 3 bearish signals across 126 daily candles, as of September 10, 2026 at 00:55 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.98 (neutral) |
| vs SMA50 | Below (USD 6.64) |
| MACD | -0.04 (negative) |
From EBS's Latest SEC 10-K Filing (filed 2026-02-27)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | USD 10.81 | ▼ 5.05% |
| QDEL | QuidelOrtho Corporation | USD 12.64 | ▼ 9.52% |
| ALNY | Alnylam Pharmaceuticals, Inc. | USD 258 | ▼ 3.05% |
| BMRN | BioMarin Pharmaceutical Inc. | USD 64.41 | ▼ 3.19% |
| BHVN | Biohaven Ltd. | USD 15 | ▼ 4.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 10, 2026 at 00:55 UTC. This page is informational and not investment advice.